<?xml version="1.0"?>
<Articles JournalTitle="Current Journal of Neurology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Vitamin D and multiple sclerosis.</title>
    <FirstPage>1</FirstPage>
    <LastPage>6</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Asghar Amini</FirstName>
        <LastName>Harandi</LastName>
        <affiliation locale="en_US">Department of Biochemistry, School of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ali Amini</FirstName>
        <LastName>Harandi</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>Pakdaman</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Ali</FirstName>
        <LastName>Sahraian</LastName>
        <affiliation locale="en_US">MS Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Multiple sclerosis (MS) is a chronic demyelinating disease and also is one of the most common disabling neurological disorders in young and middle-aged adults. The main pathogenesis of MS has long been thought to be an immune mediated disorder of the central nervous system. The function of the immune system is under the influence of vitamin D which as a modulator of immune response could play a role in autoimmune diseases including MS. Deficiency of vitamin D or variations in DNA sequence (polymorphism) of vitamin D receptor gene diminishes its optimal function on immune system that consequently could lead to increasing risk of MS. However, its role in development and modulating the course of MS is still under investigation. In this review we aimed to discuss the role of vitamin D in body, immune system and consequently altering the risk of MS.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/632</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/632/170</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Correlations between cytomegalovirus, Epstein-Barr virus, anti-ganglioside antibodies, electrodiagnostic findings and functional status in Guillain-Barr&#xE9; syndrome.</title>
    <FirstPage>7</FirstPage>
    <LastPage>12</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Aliakbar</FirstName>
        <LastName>Taheraghdam</LastName>
        <affiliation locale="en_US">Department of Neurology, Neurosciences Research Center (NSRC), School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Peyman</FirstName>
        <LastName>Pourkhanjar</LastName>
        <affiliation locale="en_US">Neurologist, Department of Neurology, Neurosciences Research Center (NSRC), School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mahnaz</FirstName>
        <LastName>Talebi</LastName>
        <affiliation locale="en_US">Department of Neurology, Neurosciences Research Center (NSRC), School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammadreza</FirstName>
        <LastName>Bonyadi</LastName>
        <affiliation locale="en_US">Department of Neurology, Neurosciences Research Center (NSRC), School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Pashapour</LastName>
        <affiliation locale="en_US">Department of Neurology, Neurosciences Research Center (NSRC), School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ehsan</FirstName>
        <LastName>Sharifipour</LastName>
        <affiliation locale="en_US">Department of Neurology, Neurosciences Research Center (NSRC), Student Research Committee, School of Medicine, Tabriz University of Medical Sciences, Imam Reza Hospital, Tabriz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Reza</FirstName>
        <LastName>Rikhtegar</LastName>
        <affiliation locale="en_US">Neurologist, Department of Neurology, Neurosciences Research Center (NSRC), School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Due to underlying autoimmune background of Guillain-Barr&#xE9; syndrome (GBS), the possible role of infectious agents cytomegalovirus&#xA0; (CMV) and&#xA0; Epstein-Barr virus (EBV) and also due to association&#xA0; of anti-ganglioside antibodies with GBS, the present study aimed to investigate the&#xA0; associations&#xA0;&#xA0; between serum anti-ganglioside antibodies (AGA) level,&#xA0; type&#xA0; of&#xA0; infection&#xA0; and electrodiagnostic (ED) findings with the severity and three- month functional outcome&#xA0; of patients with GBS.
Methods: In a prospective study, 30 patients with GBS were selected&#xA0; and before starting the treatment, baseline serum samples of patients were obtained for measuring the serum AGA including&#xA0; the&#xA0; antibodies&#xA0; against&#xA0; GQ1b, GT1b, GD1a, GD1b, GM1, GM2, GM3 and strains of CMV and EBV. All the patients&#xA0; were&#xA0; precisely examined&#xA0; for ED findings. Functional&#xA0;&#xA0; status&#xA0;&#xA0; of&#xA0; patients on&#xA0; admission and three months&#xA0; after admission were recorded&#xA0; according to the modified Rankin scale (mRS).
Results:&#xA0;The&#xA0; results of patients' serum&#xA0; assessment revealed that CMV IgM was positive in one patient (3.3%), CMV IgG in 29 patients&#xA0; (96.7%) and EBV IgG in 27 patients (90%). Anti-GM1 was found in 3 patients&#xA0; (10%) and anti- GM3 was found only in one patient&#xA0; (3.3%). However, no statistical significant association&#xA0; was found&#xA0; between the AGA and strain of the disease and ED findings.
Conclusion: Despite the coexistence&#xA0; of AGA and serum antibodies&#xA0; against&#xA0; CMV and&#xA0; EBV in some GBS patients, there&#xA0; was not clear association&#xA0; in this regard. However, the&#xA0; AGA was&#xA0; positive&#xA0; in&#xA0; patients&#xA0;&#xA0; who&#xA0; suffered&#xA0; from severe phase of the disease.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/631</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/631/171</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Level of attitude toward complementary and alternative medicine among Iranian patients with multiple sclerosis.</title>
    <FirstPage>13</FirstPage>
    <LastPage>18</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Mohammad Hossein</FirstName>
        <LastName>Harirchian</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Ali</FirstName>
        <LastName>Sahraian</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Tehran University of Medical Sciences, Sina MS Center, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Amir</FirstName>
        <LastName>Hosseinkhani</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Tehran University of Medical Sciences AND Iranian Center of Neurological Research, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Nasibeh</FirstName>
        <LastName>Amirzargar</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Tehran University of Medical Sciences AND Iranian Center of Neurological Research, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Multiple sclerosis (MS) is an unpredictable neurological disease leading to severe disability in young adults.&#xA0; The&#xA0; majority of MS patients&#xA0; use&#xA0; complementary and&#xA0;&#xA0;&#xA0;&#xA0; alternative medicine&#xA0; (CAM)&#xA0; as adjunct&#xA0; to conventional&#xA0; therapies.&#xA0; This study&#xA0; aimed&#xA0; to&#xA0; investigate the prevalence&#xA0; of CAM utilization among&#xA0; Iranian patients with MS and their attitude&#xA0; toward the CAM usage.
Methods: A cross-sectional study was conducted on 119 definite MS patients referred to Tehran&#x2019;s Imam Khomeini and Sina hospitals. A questionnaire was used to examine the association between&#xA0;&#xA0; participants&#x2019;&#xA0; health-related factors and usage&#xA0; of CAMs interventions.P value &lt; 0.05 was considered statistically significant.
Results: Among the enrolled patients, 60% of the participants agreed with using CAM, 42% experienced&#xA0; the usage of these treatments; out of whom 41% believed its efficiency and&#xA0; 18% reported exacerbation of symptoms. The mean&#xA0; duration of disease diagnosis&#xA0; and&#xA0; mean&#xA0; time from symptom onset&#xA0; were both longer in users of CAM (P = 0.001). Most socio-demographic factors had no significant effect on the type of used CAM. However, Yoga was&#xA0; significantly&#xA0; more applied&#xA0; in those with higher degree of education&#xA0; (P = 0.002).
Conclusion: Regarding the widespread use of CAM by Iranian patients with MS, further researches&#xA0; about&#xA0; the safety&#xA0; and&#xA0; efficacy of&#xA0; each&#xA0; treatment&#xA0; on&#xA0; the&#xA0; special outcomes&#xA0; is recommended.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/630</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/630/172</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Role of C-fibers in pain and morphine induced analgesia/hyperalgesia in rats.</title>
    <FirstPage>19</FirstPage>
    <LastPage>27</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Alizadeh</LastName>
        <affiliation locale="en_US">Department of Biology, Faculty of Sciences, Ferdowsi University of Mashhad, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Fereidoni</LastName>
        <affiliation locale="en_US">Department of Biology, Faculty of Sciences, Ferdowsi University of Mashhad, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Morteza</FirstName>
        <LastName>Behnam-Rassouli</LastName>
        <affiliation locale="en_US">Department of Biology, Faculty of Sciences, Ferdowsi University of Mashhad, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Shirin</FirstName>
        <LastName>Hosseini</LastName>
        <affiliation locale="en_US">Department of Biology, Faculty of Sciences, Ferdowsi University of Mashhad, Mashhad, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Usual dosage&#xA0; of morphine&#xA0; (10 mg/kg) induces&#xA0; analgesia&#xA0; and ultra-low dose (ULD) of morphine (1 &#x3BC;g/kg); hyperalgesia, and&#xA0; C-fibers are also bearing&#xA0; &#x3BC;- opioid receptors; here the importance&#xA0; of C-fibers on pain and&#xA0; morphine&#xA0;&#xA0; induced&#xA0; analgesia/hyperalgesia&#xA0; is questioned&#xA0;&#xA0; and&#xA0; investigated&#xA0;&#xA0;&#xA0; using&#xA0;&#xA0; pain&#xA0;&#xA0; evaluation methods and infant capsaicin treating&#xA0; for C-fibers lesioning.
Methods: Wistar&#xA0;&#xA0; male&#xA0;&#xA0; rats&#xA0;&#xA0; (200-250&#xA0;&#xA0; grams)&#xA0;&#xA0; were assigned&#xA0; to three&#xA0; categories&#xA0; i.e. control, sham (receiving neonatal&#xA0;&#xA0;&#xA0; capsaicin vehicle) and&#xA0; c-lesion&#xA0;&#xA0; (receiving neonatal&#xA0; capsaicin), each one&#xA0; with three&#xA0; groups&#xA0; (n = 7). They were injected intraperitoneally with single dosage of saline, 10 mg/kg or 1 &#x3BC;g/kg morphine, respectively. Thermal pain threshold&#xA0; was evaluated&#xA0; using the tail flick test before and 30 minutes&#xA0; after the injections. Chemical pain was assessed using the formalin test (FT) 30 minutes after the administrations. Results:
Results:&#xA0; indicated&#xA0; that&#xA0; thermal&#xA0; (P &lt; 0.001) and chemical&#xA0; pains&#xA0; in&#xA0; both neurogenic and inflammatory phases&#xA0; of FT (P &lt; 0.05) were reduced&#xA0; in C-lesion animals. In the C-normal and C-lesion animals, 10 mg/kg morphine exerted analgesia&#xA0; both&#xA0; in thermal&#xA0; (P &lt; 0.001) and&#xA0; two phases of FT (P &lt; 0.01), but it was more potent in C-lesion animals (P &lt; 0.05). Although ULD of morphine in C-normal animals&#xA0; produced&#xA0; hyperalgesic effect in thermal and chemical pains (P &lt; 0.001), in C-lesion animals, it produced analgesia (P &lt; 0.05) at the neurogenic phase of FT.
Conclusion: Results can raise the C-fibers involvement for a significant portion of nociceptive transmission, because C-lesioning potentiated morphine&#xA0; induced analgesia and eliminated ULD of morphine induced hyperalgesia.Therefore C and&#xA0; A&#x3B4; fibers can be&#xA0; involved in morphine analgesia; while, just C-fibers are possibly responsible&#xA0; for only presynaptically hyperalgesic/excitatory action of ULD in morphine.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/629</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/629/173</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Dietary intake of nutrients and its correlation with fatigue in multiple sclerosis patients.</title>
    <FirstPage>28</FirstPage>
    <LastPage>32</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Sama</FirstName>
        <LastName>Bitarafan</LastName>
        <affiliation locale="en_US">Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad-Hossein</FirstName>
        <LastName>Harirchian</LastName>
        <affiliation locale="en_US">Department of Neurology AND Iranian Center of Neurological Research, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Shahriar</FirstName>
        <LastName>Nafissi</LastName>
        <affiliation locale="en_US">Department of Neurology AND Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad-Ali</FirstName>
        <LastName>Sahraian</LastName>
        <affiliation locale="en_US">Department of Neurology, Sina MS Research Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mansoureh</FirstName>
        <LastName>Togha</LastName>
        <affiliation locale="en_US">Department of Neurology, Sina MS Research Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Fereydoun</FirstName>
        <LastName>Siassi</LastName>
        <affiliation locale="en_US">Department of Community Nutrition, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ahmad</FirstName>
        <LastName>Saedisomeolia</LastName>
        <affiliation locale="en_US">Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Elham</FirstName>
        <LastName>Alipour</LastName>
        <affiliation locale="en_US">Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Nakisa</FirstName>
        <LastName>Mohammadpour</LastName>
        <affiliation locale="en_US">Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Chamary</LastName>
        <affiliation locale="en_US">Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Niyaz Mohammadzadeh</FirstName>
        <LastName>Honarvar</LastName>
        <affiliation locale="en_US">Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ali-Akbar</FirstName>
        <LastName>Saboor-Yaraghi</LastName>
        <affiliation locale="en_US">Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background:&#xA0; The&#xA0; role of nutrition&#xA0; in the&#xA0; progression&#xA0; of multiple&#xA0; sclerosis (MS) and&#xA0; related&#xA0; complications&#xA0; such&#xA0; as fatigue&#xA0; has been&#xA0; reported by several studies.&#xA0; The&#xA0; aim of this&#xA0; study&#xA0; is the&#xA0; assessment of nutritional&#xA0; status&#xA0; and&#xA0; its relationship with fatigue in multiple sclerosis patients.
Methods:&#xA0; This&#xA0; is&#xA0; a&#xA0; cross-sectional study, in which&#xA0; 101 relapsing-remitting MS patients&#xA0; were enrolled.The fatigue status&#xA0; was determined using the validated&#xA0; Persian version of the&#xA0; Modified&#xA0; Fatigue Impact&#xA0; Scale (MFIS). Dietary intake was assessed using&#xA0; a&#xA0; 3-day&#xA0; food&#xA0; record questionnaire&#xA0; and&#xA0; compared&#xA0; to&#xA0; dietary&#xA0; reference&#xA0; intake (DRI)&#xA0; values.&#xA0; Association&#xA0; between variables&#xA0; was determined using Pearson Correlation Coefficient.
Results:&#xA0; In&#xA0; the&#xA0; preset&#xA0; study,&#xA0; 25&#xA0; men&#xA0; and&#xA0; 76&#xA0; women (total&#xA0; =&#xA0; 101)&#xA0; were&#xA0; enrolled.&#xA0; Analysis of&#xA0; dietary&#xA0; intake showed&#xA0; that daily intake of vitamin D, folate, calcium, and magnesium&#xA0; were&#xA0; significantly&#xA0; lower&#xA0; than&#xA0; DRI&#xA0; in&#xA0; all&#xA0; of patients.&#xA0; In&#xA0; men,&#xA0; zinc intake&#xA0; was significantly lower than DRI;&#xA0; while, in women, iron was significantly below&#xA0; the DRI level. After adjusting for energy, MFIS and its physical subscale were highly correlated with intake of folate and magnesium.
Conclusion: Our findings support that lower magnesium and folate diets are correlated with higher fatigue scores in MS patients.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/628</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/628/174</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">One-shot, low-dosage intratympanic gentamicin for M&#xE9;ni&#xE8;re's disease: Clinical, posturographic and vestibular test findings.</title>
    <FirstPage>33</FirstPage>
    <LastPage>39</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Ahmad</FirstName>
        <LastName>Daneshi</LastName>
        <affiliation locale="en_US">Department and Research Center of Otolaryngology-Head and Neck Surgery, Hazrat-e-Rasool Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hesam</FirstName>
        <LastName>Jahandideh</LastName>
        <affiliation locale="en_US">Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Behzad</FirstName>
        <LastName>Pousti</LastName>
        <affiliation locale="en_US">Department and Research Center of Otolaryngology-Head and Neck Surgery, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Shabahang</FirstName>
        <LastName>Mohammadi</LastName>
        <affiliation locale="en_US">Department and Research Center of Otolaryngology-Head and Neck Surgery, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: M&#xE9;ni&#xE8;re&#x2019;s disease&#xA0; has been&#xA0; remained&#xA0; as a difficult therapeutic&#xA0; challenge. The&#xA0; present&#xA0; study aimed to&#xA0;&#xA0; determine&#xA0;&#xA0;&#xA0; the effects of&#xA0; one-shot low-dosage intratympanic&#xA0;&#xA0; gentamicin&#xA0;&#xA0; on&#xA0; vertigo control, auditory outcomes&#xA0; and&#xA0; findings of computerized&#xA0; dynamic posturography&#xA0; and&#xA0;&#xA0; vestibular&#xA0; evoked&#xA0; myogenic potentials in patients with unilateral M&#xE9;ni&#xE8;re&#x2019;s disease.
Methods: In a prospective&#xA0; clinical study, 30 patients&#xA0; with unilateral&#xA0; M&#xE9;ni&#xE8;re&#x2019;s&#xA0; disease&#xA0; were&#xA0; treated&#xA0; with one-shot intratympanic injection of 20 milligrams gentamicin. Main outcome&#xA0;&#xA0;&#xA0;&#xA0; measures&#xA0; included clinical,&#xA0; audiometric, postural&#xA0;&#xA0; and&#xA0; vestibular&#xA0; outcomes evaluated 1 and&#xA0; 9 months after the treatment.
Results:&#xA0; Mean&#xA0; vertigo&#xA0; attacks&#xA0; frequency,&#xA0; pure&#xA0;&#xA0; tone average&#xA0; threshold&#xA0; and functional level scale significantly decreased after the treatment (P &lt; 0.05). Effective vertigo control (class A and B) obtained in 95.8% of the patients. In total, 75% of patients&#xA0; reported decrease&#xA0; in both&#xA0; aural fullness and&#xA0; tinnitus.&#xA0;&#xA0;&#xA0; Vestibular&#xA0; evoked myogenic potentials&#xA0; became&#xA0; absent&#xA0; in all the&#xA0; patients&#xA0; but&#xA0; four of them. Posturographic scores were improved after the treatment.
Conclusion: One-shot&#xA0; low-dosage&#xA0; gentamicin&#xA0; was effective&#xA0;&#xA0; in&#xA0;&#xA0; controlling vertigo attacks&#xA0; in M&#xE9;ni&#xE8;re&#x2019;s disease&#xA0; and&#xA0; has&#xA0; useful&#xA0; effects on&#xA0; aural&#xA0; fullness and tinnitus&#xA0; of patients&#xA0; as well. Postural and&#xA0; vestibular tests only have adjunctive role for monitoring&#xA0; therapeutic responses in intratympanic gentamicin-therapy.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/627</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/627/175</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Thymic pathological examination of non-thymomatous myasthenia gravis patients: A pilot study for prediction of outcome.</title>
    <FirstPage>40</FirstPage>
    <LastPage>44</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Zeinab</FirstName>
        <LastName>Peimani</LastName>
        <affiliation locale="en_US">Student Research Comittee, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Amin</FirstName>
        <LastName>Banihashemi</LastName>
        <affiliation locale="en_US">Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Niloofar</FirstName>
        <LastName>Namazi</LastName>
        <affiliation locale="en_US">Student Research Comittee, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Anahid</FirstName>
        <LastName>Safari</LastName>
        <affiliation locale="en_US">Department of Pharmacology, School of Medicine, Islamic Azad University, Kazeroon Branch, Kazeroon, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ahmad</FirstName>
        <LastName>Monabati</LastName>
        <affiliation locale="en_US">Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mehra</FirstName>
        <LastName>Mojallal</LastName>
        <affiliation locale="en_US">Department of Pathology, Dena Hospital, Shiraz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Afshin</FirstName>
        <LastName>Borhani-Haghighi</LastName>
        <affiliation locale="en_US">Health Policy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran ; Department of Neurology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background:&#xA0; Myasthenia&#xA0; gravis (MG) is an&#xA0; autoimmune disorder&#xA0;&#xA0; characterized&#xA0;&#xA0; by&#xA0; weakness&#xA0;&#xA0; and&#xA0;&#xA0; fatigability&#xA0; of skeletal muscles. The aim of this study was to determine if pathological characteristics in non-thymomatous patients of MG would correlate with prognosis in a three year follow up.
Methods:&#xA0; Patients&#xA0; who&#xA0; had&#xA0; had&#xA0; their&#xA0; thymectomy&#xA0;&#xA0; at least&#xA0; three&#xA0; years prior to&#xA0; the&#xA0; study&#xA0; were&#xA0; selected&#xA0; from three&#xA0; hospitals&#xA0; and were followed for 3 years. Prognosis was assessed&#xA0; via a devised&#xA0; prognostic&#xA0; scoring system. A pathological&#xA0; exam of the specimen&#xA0; from the thymus was done&#xA0; using the following immunohistochemical markers: Bcl2, CD 3, CD 4, CD 5, CD 7, CD 10, CD 20cy, CD 23, CD 43, and Ki67.
Results: Fifteen patients&#xA0; fulfilled the inclusion criteria and had a complete&#xA0; follow-up. This included&#xA0; 3 males and 12 females with a mean age of 36.6 years at the start of the&#xA0; study. The dominant&#xA0; cell population was T lymphocytes. All T cells expressed&#xA0; CD 3, CD 43, CD 5, and&#xA0; Bcl-2. In&#xA0; 2 patient , CD 10 marker was positive in T cells. B cells were negative for activation marker CD 23, except for germinal center&#xA0;&#xA0; dendritic&#xA0;&#xA0; cells.&#xA0; Due&#xA0; to&#xA0; the&#xA0; limited&#xA0; number&#xA0;&#xA0; of patients&#xA0; in the study, the power of the study would not allow for an analysis to assess correlation between histopathological data and prognosis.
Conclusion: This pilot study was an attempt to discover any prognostic indices from the histopathological examination&#xA0; of the resected&#xA0; thymic tissue in the patients with myasthenia gravis.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/626</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/626/176</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Increased carotid intima-media thickness in scuba divers.</title>
    <FirstPage>45</FirstPage>
    <LastPage>47</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Mehrpour</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Iran University of Medical Sciences AND Iranian Center of Neurological Research (ICNR), Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Saeed</FirstName>
        <LastName>Rezaali</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Islamic Azad University, Tehran Medical Branch, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Narges Sadat</FirstName>
        <LastName>Shams-Hosseini</LastName>
        <affiliation locale="en_US">Department of Occupational and Environmental Medicine AND Center for Research on Occupational Diseases, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Scuba divers work in high pressure conditions which may cause some changes in physiological status to adapt to this situation. In this study, the carotid intima-media thickness (CIMT) was assessed in divers as a risk factor of cerebrovascular and cardiovascular disorders.
Methods: This historical cohort study was performed on 16 male professional scuba divers as case group and 30 healthy people as controls with age range of 26-66 years. CIMT of both carotids of supine participants was measured by a 10 MHz linear ultrasonic probe quantitatively. Relationship between experience of diving and carotid IMT was evaluated.
Results: All the participants were males (mean age 42.9 &#xB1; 10.58. and for the control group was (47.05 &#xB1; 12.31 years). The mean right CIMT in divers and control group was 524.31 &#xB1; 149.40 and 443.66 &#xB1; 59.62 micrometer, respectively. Furthermore, the mean left CIMT in divers and control group was 624.57 &#xB1; 116.15 and 458.44 &#xB1; 49.56 micrometer, respectively. Conclusion: The findings demonstrated that long-term occupational diving leads to increased intima-media thickness in scuba divers.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/625</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/625/177</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Amyloid-based therapies did fail again! It is the right time to change our vision on building block of Alzheimer's disease.</title>
    <FirstPage>48</FirstPage>
    <LastPage>49</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Morteza</FirstName>
        <LastName>Mahmoudi</LastName>
        <affiliation locale="en_US">Department of Nanotechnology AND Nanotechnology Research Center, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">#No Abstract#</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/624</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/624/178</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Prevalence of Lhermitte's sign in multiple sclerosis versus neuromyelitis optica.</title>
    <FirstPage>50</FirstPage>
    <LastPage>51</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Etemadifar</LastName>
        <affiliation locale="en_US">Department of Neurology, Isfahan Neurosciences Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Noushin</FirstName>
        <LastName>Mehrbod</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Leila</FirstName>
        <LastName>Dehghani</LastName>
        <affiliation locale="en_US">Department of Medical Sciences, School of Medicine, Islamic Azad University, Najafabad Branch, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Aryan</FirstName>
        <LastName>Golabbakhsh</LastName>
        <affiliation locale="en_US">Medical Students' Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mahboobeh</FirstName>
        <LastName>Fereidan-Esfahani</LastName>
        <affiliation locale="en_US">Medical Students' Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mojtaba</FirstName>
        <LastName>Akbari</LastName>
        <affiliation locale="en_US">Department of Epidemiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Nasr</LastName>
        <affiliation locale="en_US">Medical Students' Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">No Abstract</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/623</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/623/179</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Neurotheology: The relationship between brain and religion.</title>
    <FirstPage>52</FirstPage>
    <LastPage>55</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Alireza</FirstName>
        <LastName>Sayadmansour</LastName>
        <affiliation locale="en_US">Department of Philosophy, School of Literature and Humanities, University of Tehran, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">"Neurotheology" refers to the multidisciplinary field of scholarship that seeks to understand the relationship between the human brain and religion. In its initial development, neurotheology has been conceived in very broad terms relating to the intersection between religion and brain sciences in general. The author's main objective is to introduce neurotheology in general and provides a basis for more detailed scholarship from experts in theology, as well as in neuroscience and medicine.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/622</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/622/180</pdf_url>
  </Article>
</Articles>
